Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Careium AB | CARE | 27. sep 2024 | 32.70 | +4.14 |
Case | CASE | 27. sep 2024 | 15.10 | -0.66 |
Castellum | CAST | 27. sep 2024 | 149.00 | +0.81 |
Catella A | CATA | 27. sep 2024 | 31.80 | -0.63 |
Catella B | CATB | 27. sep 2024 | 30.10 | +0.33 |
Catena | CATE | 27. sep 2024 | 573.00 | +0.17 |
Catena Media | CTM | 27. sep 2024 | 6.96 | +2.05 |
Cavendish Hydrogen | CAVENO | 27. sep 2024 | 11.00 | 0.00 |
Cavotec SA | CCC | 27. sep 2024 | 21.00 | 0.00 |
CDON | CDON | 27. sep 2024 | 62.20 | -10.37 |
Cedergrenska | CEDER | 27. sep 2024 | 30.00 | -3.23 |
Cell Impact | CI | 27. sep 2024 | 0.24 | +8.28 |
CellaVision | CEVI | 27. sep 2024 | 286.00 | +1.24 |
Cereno Scientific B | CRNOB | 27. sep 2024 | 7.00 | -2.85 |
ChargePanel AB (publ) | CHARGE | 27. sep 2024 | 1.65 | -2.37 |
Checkin.com Group | CHECK | 27. sep 2024 | 20.20 | -2.88 |
Cheffelo | CHEF | 27. sep 2024 | 27.30 | +4.60 |
Chordate Medical Holding | CMH | 27. sep 2024 | 25.66 | -4.96 |
Chosa Oncology AB | CHOSA | 27. sep 2024 | 1.10 | 0.00 |
ChromoGenics | CHRO | 27. sep 2024 | 9.78 | +0.41 |
Cibus Nordic Real Estate | CIBUS | 27. sep 2024 | 177.45 | +0.25 |
Cinclus Pharma Holding AB | CINPHA | 27. sep 2024 | 28.00 | 0.00 |
Cinis Fertilizer AB | CINIS | 27. sep 2024 | 20.80 | -0.24 |
Cint Group | CINT | 27. sep 2024 | 9.88 | +2.38 |
CirChem | CIRCHE | 27. sep 2024 | 2.70 | 0.00 |
Circle Energy Sweden B | CIRCLEB | 27. sep 2024 | 0.00 | 0.00 |
Clas Ohlson B | CLASB | 27. sep 2024 | 167.00 | -0.77 |
Clavister Holding | CLAV | 27. sep 2024 | 1.72 | +2.39 |
Clean Motion | CLEMO | 27. sep 2024 | 0.57 | +1.77 |
Clemondo Group | CLEM | 27. sep 2024 | 0.81 | +1.25 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.